← Leaderboards
Huw M Davies
Wake Forest University
$9,857,643
Attributed
$9,857,643
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $687.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,857,643 · 8
By mechanism
R01$8,506,873 · 6
P50$977,653 · 1
R35$373,117 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University
Same institution · by research overlap
- Linda J. Porrino$16,682,396
- Kent E Vrana$8,052,963
- Barbara A Bennett$701,325
- David Charles Stephen Roberts$4,832,765
- Ross P Holmes$8,401,825
Others in their field
Top investigators on “Reaction”
- Richard A Gibbs · Baylor College Of Medicine$161,470,157
- David R. Weir · University Of Michigan At Ann Arbor$82,494,797
- Norman Wolmark · Nsabp Foundation, Inc.$79,120,134
- David Heimbrook · Leidos Biomedical Research, Inc.$77,952,177
- Constance Ann Benson · University Of California, San Diego$66,635,731
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
ReactionRhodiumPharmacologic SubstanceInterestMethodologyPharmaceutical PreparationsCocaineDesignChemistryOrganic SynthesisSiteSchemeCatalystScaffoldProgramsBiomedical ResearchLigandsBiological FactorsSeriesStructureAnalogDrug DesignBiologicalDna Sequence Rearrangement
Grant awards (37)
Novel Bowl-shaped Catalysts for Selective C-H Functionalization$373,117
R35 · FY2025 · GM · contact PI
New Directions in Enantioselective C-H Functionalization$356,753
R01 · FY2023 · GM · contact PI
New Directions in Enantioselective C-H Functionalization$356,753
R01 · FY2022 · GM · contact PI
New Directions in Enantioselective C-H Functionalization$356,753
R01 · FY2021 · GM · contact PI
New Directions in Enantioselective C-H Functionalization$356,753
R01 · FY2020 · GM · contact PI
N-Sulfonyltriazoles as Carbene Precursors$357,930
R01 · FY2018 · GM · contact PI
N-Sulfonyltriazoles as Carbene Precursors$358,717
R01 · FY2017 · GM · contact PI
N-Sulfonyltriazoles as Carbene Precursors$359,435
R01 · FY2016 · GM · contact PI
N-Sulfonyltriazoles as Carbene Precursors$360,086
R01 · FY2015 · GM · contact PI
Enantioselective Zwitterionic Reactions$353,552
R01 · FY2014 · GM · contact PI
Diversity Supplement: Enantioselective Zwitterionic Reactions$21,252
R01 · FY2014 · GM · contact PI
Enantioselective Zwitterionic Reactions$279,655
R01 · FY2013 · GM · contact PI
Enantioselective Zwitterionic Reactions$289,798
R01 · FY2012 · GM · contact PI
Enantioselective Zwitterionic Reactions$289,798
R01 · FY2011 · GM · contact PI
Design of New Treatment Agents for Drug Abuse$379,450
R01 · FY2010 · DA · contact PI
Application of C-H Activation to Natural Product Synthesis$291,555
R01 · FY2010 · GM · contact PI
Design of New Treatment Agents for Drug Abuse$393,200
R01 · FY2009 · DA · contact PI
Application of C-H Activation to Natural Product Synthesis$294,500
R01 · FY2009 · GM · contact PI
Application of C-H Activation to Natural Product Synthesis$230,293
R01 · FY2008 · GM · contact PI
CORE--CHEMISTRY$143,071
P50 · FY2008 · DA · contact PI
Application of C-H Activation to Natural Product Synthesis$65,591
R01 · FY2008 · GM · contact PI
Application of C-H Activation to Natural Product Synthesis$300,117
R01 · FY2007 · GM · contact PI
CORE--CHEMISTRY$133,257
P50 · FY2007 · DA · contact PI
Methylphenidate Analogs as Medications for Cocaine Abuse$297,693
R01 · FY2006 · DA · contact PI
Methylphenidate Analogs as Medications for Cocaine Abuse$304,857
R01 · FY2005 · DA
Methylphenidate Analogs as Medications for Cocaine Abuse$304,857
R01 · FY2004 · DA
Methylphenidate Analogs as Medications for Cocaine Abuse$304,390
R01 · FY2003 · DA
Methylphenidate Analogs as Medications for Cocaine Abuse$316,906
R01 · FY2002 · DA
SYNTHESIS AND EVALUATION OF NOVEL COCAINE ANALOGS$234,809
R01 · FY2002 · DA
CORE--CHEMISTRY, SYNTHESIS OF NOVEL TROPANES FOR BIOLOGICAL EVALUATION$191,175
P50 · FY2002 · DA
SYNTHESIS AND EVALUATION OF NOVEL COCAINE ANALOGS$227,968
R01 · FY2001 · DA
CORE--CHEMISTRY, SYNTHESIS OF NOVEL TROPANES FOR BIOLOGICAL EVALUATION$191,175
P50 · FY2001 · DA
SYNTHESIS OF CP-263,114--NEW RAS FARNESYLATION INHIBITOR$122,850
R01 · FY2001 · CA
SYNTHESIS AND EVALUATION OF NOVEL COCAINE ANALOGS$221,329
R01 · FY2000 · DA
CORE--CHEMISTRY, SYNTHESIS OF NOVEL TROPANES FOR BIOLOGICAL EVALUATION$191,175
P50 · FY2000 · DA
CORE--CHEMISTRY, SYNTHESIS OF NOVEL TROPANES FOR BIOLOGICAL EVALUATION$127,800
P50 · FY2000 · DA
SYNTHESIS OF CP-263,114--NEW RAS FARNESYLATION INHIBITOR$119,273
R01 · FY2000 · CA